| 注册
首页|期刊导航|中国药房|NF-κB信号通路在急性肺损伤中的作用及中药干预研究进展

NF-κB信号通路在急性肺损伤中的作用及中药干预研究进展

刘馥溧 巴元明

中国药房2025,Vol.36Issue(10):1277-1282,6.
中国药房2025,Vol.36Issue(10):1277-1282,6.DOI:10.6039/j.issn.1001-0408.2025.10.22

NF-κB信号通路在急性肺损伤中的作用及中药干预研究进展

Research progress on the role of NF-κB signaling pathway in acute lung injury and TCM intervention

刘馥溧 1巴元明2

作者信息

  • 1. 湖北中医药大学中医学院,武汉 430061
  • 2. 湖北中医药大学附属医院肾内科,武汉 430061
  • 折叠

摘要

Abstract

Acute lung injury(ALI)is a common clinical inflammatory respiratory emergency with high morbidity and mortality,for which there is no effective and safe therapeutic drug.Nuclear factor-κB(NF-κB),as a classic inflammatory signaling pathway,can interact with upstream and downstream regulatory factors such as Toll-like receptor 4(TLR4),mitogen-activated protein kinase(MAPK),nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor 3(NLRP3),high mobility group box-1 protein 1(HMGB1),to jointly affect ALI.This review summarizes the latest research findings in recent years regarding the treatment of ALI through traditional Chinese medicine(TCM)interventions targeting NF-κB signaling pathways.It has been found that a variety of TCM monomers(danshensu methyl ester,salidroside total glycosides,berberine,Codonopsis pilosula polysaccharides,ursolic acid,chrysophanol,and polyphenols from longan seed kernels,etc.)and compound formulas(Resolving-dampness and defeating-toxins formula,Jinyin qingre oral liquid,Xuebijing injection,Combined treatment of lung and intestine,Huangqi baihe decoction,etc.)can modulate NF-κB signaling pathway,and can prevent and control ALI by inhibiting inflammation,improving oxidative stress,reducing apoptosis and modulating the intestinal flora in a multi-pathway manner.

关键词

NF-κB信号通路/急性肺损伤/中药/机制

Key words

NF-κB signaling pathway/acute lung injury/traditional Chinese medicine/mechanism

分类

医药卫生

引用本文复制引用

刘馥溧,巴元明..NF-κB信号通路在急性肺损伤中的作用及中药干预研究进展[J].中国药房,2025,36(10):1277-1282,6.

基金项目

全国名老中医药专家传承工作室建设项目(No.国中医药人教函[2022]75号) (No.国中医药人教函[2022]75号)

湖北省科技重大项目(No.2022ACA003-03) (No.2022ACA003-03)

湖北中医药大学重大项目(No.2023ZDXM001) (No.2023ZDXM001)

中国药房

OA北大核心

1001-0408

访问量0
|
下载量0
段落导航相关论文